BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18156783)

  • 1. Effects of PEGylated scFv antibodies against Plasmodium vivax duffy binding protein on the biological activity and stability in vitro.
    Kim SH; Lee YS; Hwang SY; Bae GW; Nho K; Kang SW; Kwak YG; Moon CS; Han YS; Kim TY; Kho WG
    J Microbiol Biotechnol; 2007 Oct; 17(10):1670-4. PubMed ID: 18156783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-chain antibody fragment specific for Plasmodium vivax Duffy binding protein.
    Kim SH; Hwang SY; Lee YS; Choi IH; Park SG; Kho WG
    Clin Vaccine Immunol; 2007 Jun; 14(6):726-31. PubMed ID: 17460118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice.
    Devi YS; Mukherjee P; Yazdani SS; Shakri AR; Mazumdar S; Pandey S; Chitnis CE; Chauhan VS
    Vaccine; 2007 Jul; 25(28):5166-74. PubMed ID: 17544179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein (PvDBP-II) equally block erythrocyte binding of homologous and heterologous expressed PvDBP-II on the surface of COS-7 cells.
    Valizadeh V; Zakeri S; Mehrizi AA; Mirkazemi S; Djadid ND
    Med Microbiol Immunol; 2016 Feb; 205(1):85-95. PubMed ID: 26243337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium vivax Duffy binding protein: baseline antibody responses and parasite polymorphisms in a well-consolidated settlement of the Amazon Region.
    Kano FS; Sanchez BA; Sousa TN; Tang ML; Saliba J; Oliveira FM; Nogueira PA; Gonçalves AQ; Fontes CJ; Soares IS; Brito CF; Rocha RS; Carvalho LH
    Trop Med Int Health; 2012 Aug; 17(8):989-1000. PubMed ID: 22643072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-allele specific antibody responses to genetically distinct variant forms of Plasmodium vivax Duffy binding protein (PvDBP-II) in Iranians exposed to seasonal malaria transmission.
    Valizadeh V; Zakeri S; Mehrizi AA; Djadid ND
    Acta Trop; 2014 Aug; 136():89-100. PubMed ID: 24704284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of structural elements in Plasmodium vivax and P. knowlesi Duffy-binding domains necessary for erythrocyte invasion.
    Singh SK; Singh AP; Pandey S; Yazdani SS; Chitnis CE; Sharma A
    Biochem J; 2003 Aug; 374(Pt 1):193-8. PubMed ID: 12775212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax.
    Gupta S; Singh S; Popovici J; Roesch C; Shakri AR; Guillotte-Blisnick M; Huon C; Menard D; Chitnis CE
    Sci Rep; 2018 Jul; 8(1):10511. PubMed ID: 30002416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenic drift in the ligand domain of Plasmodium vivax duffy binding protein confers resistance to inhibitory antibodies.
    VanBuskirk KM; Cole-Tobian JL; Baisor M; Sevova ES; Bockarie M; King CL; Adams JH
    J Infect Dis; 2004 Nov; 190(9):1556-62. PubMed ID: 15478059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein.
    Grimberg BT; Udomsangpetch R; Xainli J; McHenry A; Panichakul T; Sattabongkot J; Cui L; Bockarie M; Chitnis C; Adams J; Zimmerman PA; King CL
    PLoS Med; 2007 Dec; 4(12):e337. PubMed ID: 18092885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.
    Zakeri S; Babaeekhou L; Mehrizi AA; Abbasi M; Djadid ND
    Am J Trop Med Hyg; 2011 Jun; 84(6):944-50. PubMed ID: 21633032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for inhibition of Plasmodium vivax invasion by a broadly neutralizing vaccine-induced human antibody.
    Rawlinson TA; Barber NM; Mohring F; Cho JS; Kosaisavee V; Gérard SF; Alanine DGW; Labbé GM; Elias SC; Silk SE; Quinkert D; Jin J; Marshall JM; Payne RO; Minassian AM; Russell B; Rénia L; Nosten FH; Moon RW; Higgins MK; Draper SJ
    Nat Microbiol; 2019 Sep; 4(9):1497-1507. PubMed ID: 31133755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein.
    Yazdani SS; Shakri AR; Mukherjee P; Baniwal SK; Chitnis CE
    Vaccine; 2004 Sep; 22(27-28):3727-37. PubMed ID: 15315853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
    Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
    J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of single versus mixed allele vaccines of Plasmodium vivax Duffy binding protein region II.
    Ntumngia FB; Schloegel J; McHenry AM; Barnes SJ; George MT; Kennedy S; Adams JH
    Vaccine; 2013 Sep; 31(40):4382-8. PubMed ID: 23916294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cloning, expression and identification of Plasmodium vivax Duffy binding protein region II of central China isolate].
    Liu D; Xia H; Tao ZY; Chen Y; Fang Q; Wang XM; Sun X; Gao Y; Mai YQ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Aug; 24(4):474-7. PubMed ID: 23236803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.
    Nicolete VC; Frischmann S; Barbosa S; King CL; Ferreira MU
    J Infect Dis; 2016 Nov; 214(10):1539-1546. PubMed ID: 27578850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted deletion of Plasmodium knowlesi Duffy binding protein confirms its role in junction formation during invasion.
    Singh AP; Ozwara H; Kocken CH; Puri SK; Thomas AW; Chitnis CE
    Mol Microbiol; 2005 Mar; 55(6):1925-34. PubMed ID: 15752210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly stable polyethylene glycol-conjugated human single-chain antibody neutralizing granulocyte-macrophage colony stimulating factor at low nanomolar concentration.
    Krinner EM; Hepp J; Hoffmann P; Bruckmaier S; Petersen L; Petsch S; Parr L; Schuster I; Mangold S; Lorenczewski G; Lutterbüse P; Buziol S; Hochheim I; Volkland J; Mølhøj M; Sriskandarajah M; Strasser M; Itin C; Wolf A; Basu A; Yang K; Filpula D; Sørensen P; Kufer P; Baeuerle P; Raum T
    Protein Eng Des Sel; 2006 Oct; 19(10):461-70. PubMed ID: 16868004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and evaluation of universal epitopes in Plasmodium vivax Duffy binding protein.
    Saravia C; Martinez P; Granados DS; Lopez C; Reyes C; Patarroyo MA
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1279-83. PubMed ID: 19000655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.